Sign in

NCT05335122CompletedPhase 2

A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

A Prospective, Multi-center, Randomized, Parallel-group, Controlled Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant in Subjects With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

To assess efficacy, and safety of a single sustained release dose of the OTX-TIC drug product (2 travoprost dose strengths) in subjects with Open Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
83 (actual)
First submitted
12 Apr 2022
Start date
16 Mar 2022
Primary completion date
24 Jan 2024
Lead sponsor
Ocular Therapeutix, Inc.
NCT number
NCT05335122

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 83
  • From 16 Mar 2022 to the primary completion date, 24 Jan 2024
  • 29 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have an uncontrolled systemic disease or a debilitating disease (e.g., cardiovascular, hypertension, uncontrolled diabetes)

Other

  • Are currently pregnant or breast-feeding or of childbearing potential without the use of adequate contraceptive methods during the length of the study
  • Non-responsive to topical prostaglandins, prostamides or prostaglandin analogs

Who the study is looking for

  • Are 18 years of age or older at the time of screening
  • Provide written informed consent and are able to comply with all study requirements
  • Are willing to withhold glaucoma medications according to the study requirements, and in the opinion of the investigator can do so without significant risk
  • Have a negative pregnancy test result for women of childbearing potential at Baseline
  • Have a documented diagnosis of OHT, or OAG in the study eye

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (29)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
AustinUnited StatesUnknown status
Ocular Therapeutix Inc
Coordinator of this site? Confirm its status
CarmelUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
ClearwaterUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
Cranberry TownshipUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status
Ocular Therapeutiux, Inc.
Coordinator of this site? Confirm its status
Delray BeachUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
DothanUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
DoverUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
DurhamUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
El PasoUnited StatesUnknown status
Ocular Therapeutiux, Inc.
Coordinator of this site? Confirm its status
FargoUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
Fort MyersUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
Huntington BeachUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
IrvineUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
KenoshaUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Ocular Therapeutix Inc
Coordinator of this site? Confirm its status
Oklahoma CityUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
PasadenaUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
PetalumaUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
RedlandsUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
Rock IslandUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
RoswellUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
Saint JosephUnited StatesUnknown status
Ocular Therapeutix Inc.
Coordinator of this site? Confirm its status
St LouisUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
TorranceUnited StatesUnknown status
Ocular Therapeutix, Inc.
Coordinator of this site? Confirm its status
TroyUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.